Has your bladder cancer not responded to BCG therapy?
We know the journey with bladder cancer is difficult. We believe there should be more options after bacillus Calmette-Guérin (BCG) therapy and before bladder removal, which is why we designed the LEGEND study.
The LEGEND study is a clinical research study (also called a clinical trial) for people with non-muscle invasive bladder cancer (NMIBC). The study is testing an investigational study drug that may help the body destroy cancer cells to ultimately either delay, or ideally, prevent bladder removal for people with NMIBC.
If you have NMIBC that is not responding to BCG therapy, we hope you will consider joining the LEGEND study. Together we could uncover new treatment options for patients with bladder cancer.